Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-05-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$507.8m
reported value
-17.7% vs Q1 2022
27positions
74.1%in top 10
7 new
6 added
5 reduced
7 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TRICIDA INC TCDA | $69.0m13.60% | Added +2.6m |
| ACLARIS THERAPEUTICS INC ACRS | $63.7m12.55% | Unchanged |
| RELMADA THERAPEUTICS INC RLMD | $43.1m8.49% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $41.5m8.17% | Reduced -283.9k |
| COGENT BIOSCIENCES INC COGT | $36.4m7.17% | Added +2.9m |
| GH RESEARCH PLC GHRS | $31.8m6.26% | Added +1.1m |
| INSTIL BIO INC COM | $27.7m5.46% | Reduced -867.4k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $23.3m4.59% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $21.4m4.22% | Unchanged |
| VISTAGEN THERAPEUTICS INC VTGN | $18.2m3.59% | Added +4.7m |
| MARINUS PHARMACEUTICALS INC MRNS | $15.3m3.01% | Unchanged |
| AADI BIOSCIENCE INC WHWK | $14.5m2.85% | Reduced -355.9k |
| INOZYME PHARMA INC COM | $12.9m2.55% | New |
| AKOUOS INC COM | $12.5m2.46% | New |
| LIANBIO LIANY | $11.6m2.29% | Unchanged |
| AEROVATE THERAPEUTICS INC COM | $9.2m1.82% | Added +439.4k |
| TREVI THERAPEUTICS INC TRVI | $8.6m1.69% | New |
| CHINOOK THERAPEUTICS INC ADRO | $8.6m1.69% | Reduced -794.2k |
| ANNEXON INC ANNX | $7.3m1.43% | New |
| SAVARA INC SVRA | $6.3m1.23% | Added +2.2m |
| LYRA THERAPEUTICS INC LYRA | $5.2m1.03% | New |
| PROVENTION BIO INC PRVB | $4.5m0.88% | Unchanged |
| ALTIMMUNE INC ALT | $4.3m0.85% | Reduced -390.4k |
| ATYR PHARMA INC ATYR | $4.0m0.78% | Unchanged |
| AFFIMED N V COM | $4.0m0.78% | Unchanged |
| RALLYBIO CORP COM | $2.0m0.40% | New |
| XENON PHARMACEUTICALS INC XENE | $913.0k0.18% | New |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| ATHIRA PHARMA INC | $13.5m1.0m shares |
| EIGER BIOPHARMACEUTICALS INC CLDN | $12.2m1.5m shares |
| NUVALENT INC | $11.2m804.0k shares |
| GRAPHITE BIO INC GRPH | $8.2m1.6m shares |
| SIERRA ONCOLOGY INC | $5.2m162.5k shares |
| CENTESSA PHARMACEUTICALS PLC | $3.7m411.4k shares |
| ASTRIA THERAPEUTICS INC CATB | $3.6m539.0k shares |